Related Experiment Video
Updated: Jun 6, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Use of attenuated paramyxoviruses for cancer therapy
Patrycja J Lech1, Stephen J Russell
1Mayo Clinic, Department of Molecular Medicine, 200 1st Street SW, Rochester, MN 55905, USA. lech.patrycja@mayo.edu
Abstract:
Paramyxoviruses, measles virus (MV), mumps virus (MuV) and Newcastle disease virus (NDV), are well known for causing measles and mumps in humans and Newcastle disease in birds. These viruses have been tamed (attenuated) and successfully used as vaccines to immunize their hosts. Remarkably, pathogenic MuV and vaccine strains of MuV, MV and NDV efficiently infect and kill cancer cells and are consequently being investigated as novel cancer therapies (oncolytic virotherapy). Phase I/II clinical trials have shown promise but treatment efficacy needs to be enhanced. Technologies being developed to increase treatment efficacy include: virotherapy in combination with immunosuppressive drugs (cyclophosphamide); retargeting of viruses to specific tumor types or tumor vasculature; using infected cell carriers to protect and deliver the virus to tumors; and genetic manipulation of the virus to increase viral spread and/or express transgenes during viral replication. Transgenes have enabled noninvasive imaging or tracking of viral gene expression and enhancement of tumor destruction.
Insights
Paramyxoviruses like measles virus are being explored as oncolytic virotherapy for cancer. Researchers are developing strategies to enhance the efficacy of these viral cancer treatments.
Area of Science:
- Virology
- Oncology
- Immunology
Background:
- Paramyxoviruses, including measles virus (MV), mumps virus (MuV), and Newcastle disease virus (NDV), are known human and avian pathogens.
- Attenuated strains of these viruses are successfully used as vaccines.
- Pathogenic MuV and vaccine strains of MuV, MV, and NDV exhibit oncolytic properties, infecting and killing cancer cells.
Purpose of the Study:
- To review current strategies for enhancing oncolytic virotherapy efficacy.
- To highlight advancements in using paramyxoviruses as cancer treatments.
Main Methods:
- Investigating combination therapies, such as virotherapy with cyclophosphamide.
- Exploring virus retargeting to specific tumor types or vasculature.
- Utilizing infected cell carriers for improved virus delivery and protection.
- Employing genetic manipulation for increased viral spread and transgene expression.
Main Results:
- Phase I/II clinical trials show promise for oncolytic virotherapy.
- Transgene expression allows for noninvasive imaging and tracking of viral activity.
- Engineered viruses can enhance tumor destruction and viral spread.
Conclusions:
- Oncolytic virotherapy using paramyxoviruses is a promising cancer treatment strategy.
- Ongoing technological developments aim to improve treatment efficacy and patient outcomes.
- Further research and clinical trials are essential to fully realize the potential of viral-based cancer therapies.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

